Fig. 2 | Scientific Reports

Fig. 2

From: Immunogenicity of Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in long-term survivors after allogeneic hematopoietic stem cell transplantation

Fig. 2

Reduced spike 1 specific immune responses in allo-HSCT recipients on immunosuppressive treatment. (A) shows serum levels of immunoglobulin G (IgG) against the receptor binding domain (RBD) of spike 1 in patients on immunosuppression (IS) compared to patients not receiving immunosuppression (non-IS). (B) shows interferon-γ (IFN-γ) and (C) shows IL-2 production in plasma supernatant following stimulation of whole blood with spike 1 peptides patients on immunosuppression compared to patients not receiving immunosuppression. Median with 95% confidence interval. Statistical comparisons by Mann-Whitney U-test. P-values are two-sided.

Back to article page